Gastrin stimulates the VEGF-A promotor in a human colon cancer cell line

Regulatory Peptides

Volumn 165, Issue 2-3, 2010, Pages 146-150

  Ellrichmann, Mark ^a   Ritter, Peter R ^a   Schrader, Henning ^a   Schmidt, Wolfgang E ^a   Meier, Juris J ^a   Schmitz, Frank ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b Klinikum Hildesheim   (Germany)

Author keywords

Colorectal cancer; Gastrointestinal hormones; Tumour angiogenesis

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; GASTRIN 17; GASTRIN RECEPTOR; VASCULOTROPIN A;

ARTICLE; CANCER CELL; CELL LEVEL; COLON CANCER; COLON CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE ACTIVITY; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION; REACTION TIME; TUMOR PROMOTION; WILD TYPE;

CELL LINE, TUMOR; COLONIC NEOPLASMS; GASTRINS; HORMONES; HUMANS; PROMOTER REGIONS, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CITRUS MACROPHYLLA;

EID: 78649831541     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.06.004     Document Type: Article

References (29)

1. Zheng S., Han M.Y., Xiao Z.X., Peng J.P., Dong Q. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol 2003, 9(6):1227-1230.
2. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology 2005, 69(Suppl 3):4-10.
3. Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999, 13(1):9-22.
4. Ryuto M., Ono M., Izumi H., Yoshida S., Weich H.A., Kohno K., et al. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 1996, 271(45):28220-28228.
5. Pertovaara L., Kaipainen A., Mustonen T., Orpana A., Ferrara N., Saksela O., et al. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 1994, 269(9):6271-6274.
6. Li J., Perrella M.A., Tsai J.C., Yet S.F., Hsieh C.M., Yoshizumi M., et al. Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J Biol Chem 1995, 270(1):308-312.
7. Jayasinghe C., Simiantonaki N., Michel-Schmidt R., Kirkpatrick C.J. Comparative study of human colonic tumor-derived endothelial cells (HCTEC) and normal colonic microvascular endothelial cells (HCMEC): hypoxia-induced sVEGFR-1 and sVEGFR-2 levels. Oncol Rep 2009, 21(4):933-939.
8. Thorburn C.M., Friedman G.D., Dickinson C.J., Vogelman J.H., Orentreich N., Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998, 115(2):275-280.
9. Agréus L., Storskrubb T., Aro P., Ronkainen J., Talley N.J., Sipponen P. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scand J Gastroenterol 2009, 44(5):564-570.
10. Robertson D.J., Larsson H., Friis S., Pedersen L., Baron J.A., Sørensen H.T. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 2007, 133(3):755-760.
11. Chubak J., Boudreau D.M., Rulyak S.J., Mandelson M.T. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf 2009, 18(7):540-544.
12. Smith A.M., Watson S.A. Review article: gastrin and colorectal cancer. Aliment Pharmacol Ther 2000, 14(10):1231-1247.
13. Schmitz F., Otte J.M., Stechele H.U., Reimann B., Banasiewicz T., Fölsch U.R., et al. CCK-B/gastrin receptors in human colorectal cancer. Eur J Clin Invest 2001, 31(9):812-820.
14. D'Onghia V., Leoncini R., Carli R., Santoro A., Giglioni S., Sorbellini F., et al. Circulating gastrin and ghrelin levels in patients with colorectal cancer: correlation with tumour stage, Helicobacter pylori infection and BMI. Biomed Pharmacother 2007, 61(2-3):137-141.
15. Yu H.G., Tong S.L., Ding Y.M., Ding J., Fang X.M., Zhang X.F., et al. Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase. Int J Cancer 2006, 119(12):2724-2732.
16. Hartwich J., Konturek S.J., Pierzchalski P., Zuchowicz M., Konturek P.C., Bielański W., et al. Molecular basis of colorectal cancer-role of gastrin and cyclooxygenase-2. Med Sci Monit 2001, 7(6):1171-1181.
17. Takhar A.S., Eremin O., Watson S.A. The role of gastrin in colorectal carcinogenesis. Surgeon 2004, 2(5):251-257.
18. Zafirellis K., Agrogiannis G., Zachaki A., Gravani K., Karameris A., Kombouras C. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer. J Surg Res 2001, 147(1):99-107.
19. Sanduleanu S., Stridsberg M., Jonkers D., Hameeteman W., Biemond I., Lundqvist G., et al. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. Aliment Pharmacol Ther 1999, 13(2):145-153.
20. Friis-Hansen L. Achlorhydria is associated with gastric microbial overgrowth and development of cancer: lessons learned from the gastrin knockout mouse. Scand J Clin Lab Invest 2006, 66(7):607-621.
21. Ciccotosto G.D., McLeish A., Hardy K.J., Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995, 109(4):1142-1153.
22. Colucci R., Blandizzi C., Tanini M., Vassalle C., Breschi M.C., Del Tacca M. Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production. Br J Pharmacol 2005, 144(3):338-348.
23. Sobhani I., Lehy T., Laurent-Puig P., Cadiot G., Ruszniewski P., Mignon M. Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 1993, 105(1):22-30.
24. van Soest E.M., van Rossum L.G., Dieleman J.P., van Oijen M.G., Siersema P.D., Sturkenboom M.C., et al. Proton pump inhibitors and the risk of colorectal cancer. Am J Gastroenterol 2008, 103(4):966-973.
25. Robertson D.J., Larsson H., Friis S., Pedersen L., Baron J.A., Sørensen H.T. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology 2007, 133(3):755-760.
26. Schäfer G., Cramer T., Suske G., Kemmner W., Wiedenmann B., Höcker M. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol Chem 2003, 278(10):8190-8198.
27. Baldwin G.S., Shulkes A. Gastrin, gastrin receptors and colorectal carcinoma. Gut 1998, 42(4):581-584.
28. Ogunwobi O.O., Beales I.L. Glycine-extended gastrin stimulates proliferation and inhibits apoptosis in colon cancer cells via cyclo-oxygenase-independent pathways. Regul Pept 2006, 134(1):1-8.
29. Biagini P., Monges G., Vuaroqueaux V., Parriaux D., Cantaloube J.F., De Micco P. The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines. Life Sci 1997, 61(10):1009-1018.